Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » Celebrating one year of the Optimal Care Pathway for people with NETs

Celebrating one year of the Optimal Care Pathway for people with NETs

  • January 24, 2024

As we celebrate the first anniversary of the launch of the Optimal Care Pathway (OCP) for NETs, we reflect on a year of dedicated efforts to enhance patient care, improve health outcomes and increase awareness of the OCP.

Over the past 12 months, NECA has undertaken numerous initiatives, from guiding patients through the OCP via NET Nurse phone calls, to  providing links for GPs to view the quick reference guide of the OCP and also providing valuable information at conferences for healthcare professionals.

Our commitment extends to fostering community engagement through NET Patient Forums, and we’ve developed user-friendly web pages for both patients and Healthcare Professionals.

Inclusive of our recent awareness campaign, the OCP has been a focal point in our endeavors to ensure Healthcare Professionals know referral pathways and appropriate investigations. We invite patients and caregivers to click on our website to explore the wealth of resources available and learn more about the  world first Optimal Care Pathway for NETs.

In July 2023 (5 months after the OCP launch) NECA worked with an Intern from Radboud University Netherlands , Zoë Teunissen to assess the impact of the OCP launch and to identify strategies to optimise its’ dissemination and effectiveness. This study was completed in December 2023.

Many thanks to the 95 questionnaire respondents who took part in this study.

Some key take outs are:-

With this group of respondents, with patients diagnosed post 2021,  their length of time to diagnosis had decreased by around 50%, highlighting the benefits of increased NET awareness. Whilst we still have a long way to go, this is a step in the right direction.

73% of patients were still unaware of the OCP, whilst 35% of patients felt that their HCP was also unaware of the OCP. It’s important to note that OCPs are (across the board) relatively new, and we can see we still have much work to do in promoting this to patients and HCPs.

95 Patients have sought supportive care from 215 Healthcare Professionals, creating an even stronger case for the need for specialist NET Nurses in each state of Australia. 52% patients sought support from GPs, followed closely by NECAs NET Nurse (47%). 35% sought support from a dietician and 18.9% a psychologist.

A great summary of the need for all HCPs and NET patients to be made aware of the OCP is a comment from one patient who noted: ‘So if I had breast cancer or cervical cancer, everyone would just know about it straight away and they would go, this is where you go, this is what you do. But with this it’s not like that at all.’

It is, therefore, crucial to ensure that communicative strategies are used to educate patients  and healthcare professionals about the OCP, to maximise the best outcomes for NET patients.

Patients indicated that they want their healthcare professionals to supply them with the OCP at diagnosis.

Respondents responses on how the OCP is useful for them

Click here to read full report

Share this post

Recent posts

Be the Voice for NET Patients in WA – Join Our CAG Team

June 10, 2025

BioPharmaDispatch 2025: Putting NETs on the National Agenda

May 27, 2025

WA Cancer Forum

May 27, 2025

ANZSNM 55th annual conference in Melbourne – Australia

May 27, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNeuroEndocrine Cancer Australia are delighted to announce a new donor partnership.
NextNECA presents alongside Peter MacCallum Cancer Centre at the Senate InquiryNext

Related Posts

Be the Voice for NET Patients in WA – Join Our CAG Team

Call out for a consumer advisory representative from Western Australia (voluntary position) Are you from Western Australia? Have you experienced a diagnosis of a Neuroendocrine

BioPharmaDispatch 2025: Putting NETs on the National Agenda

BioPharmaDispatch 2025: Putting NETs on the National Agenda NeuroEndocrine Cancer Australia was proud to attend the BioPharmaDispatch 2025 Conference in Sydney this month, represented by

WA Cancer Forum

The Cancer Network WA, in collaboration with the WA Clinical Oncology Group at Cancer Council WA,  held its second annual one-day symposium “Cancer Network Forum

ANZSNM 55th annual conference in Melbourne – Australia

Thank you to Simone Leyden AM, Director Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals Limited ARCS Australia, for organising sponsorship for a group

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin